The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

Subjects:

Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

Subjects:

Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

Subjects:

The values of angiotensin II by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

Subjects:

General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

Subjects:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

Subjects:

Minimal data set. by Pornpan Chalermkitpanit (22110121)

Subjects:

Univariate and multivariate analysis of variables associated with good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The correlation between clinical presentations and baseline serum inflammatory cytokines before TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The serum concentrations of cytokines between good responders and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

Demographic data and baseline characteristics between good and poor responders to TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

The correlation between the duration of pain symptoms and baseline serum inflammatory cytokine levels before TFESI. by Pornpan Chalermkitpanit (22110121)

Subjects:

Supplementary results_detailed. by Pornpan Chalermkitpanit (22110121)

Subjects:

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Survey-weighted association of flavonoids and six subclasses intake with MASLD. by Yuwei He (1565941)

Subjects:

Survey-weighted baseline characteristic of the study population by MASLD. by Yuwei He (1565941)

Subjects:

Weighted Quantile Sum model regression index weights for the MASLD. by Yuwei He (1565941)

Subjects: